News

The Value Stock With a Hidden Growth Engine
The Value Stock With a Hidden Growth Engine
Most investors overlook hospital stocks — but Universal Health Services (UHS) is hiding a behavioral health growth engine that could make it one of the most undervalued plays in today's shaky market.
a month ago•Corbin Buff
UHS
3 New Strong Buy Ratings from Top-Rated Analysts: 02/26/2026
3 New Strong Buy Ratings from Top-Rated Analysts: 02/26/2026
Diebold Nixdorf (DBD) has surged over 130% from its 52-week low — plus 2 more high-rated stocks, could be your next big winners.
a month ago•Jessie Moore
DBD
TCMD
ESI
3 Strong Buy Value Stocks To Add To Your Portfolio
3 Strong Buy Value Stocks To Add To Your Portfolio
Value is not dead — and these 3 high-potential stocks prove it. Including Nutex (NUTX) and more.
a month ago•Mijuško Šibalić
NUTX
TEX
KBR
Why Wall Street Is Going Crazy for Spotify (SPOT)
Why Wall Street Is Going Crazy for Spotify (SPOT)
Spotify (SPOT) just dropped 38% — but Wall Street analysts are calling it the buying opportunity of the decade with a jaw-dropping 46% upside target.
a month ago•Mijuško Šibalić
SPOT
3 New Strong Buy Ratings from Top-Rated Analysts: 02/24/2026
3 New Strong Buy Ratings from Top-Rated Analysts: 02/24/2026
Roku (ROKU) is projecting 73% earnings growth — and it's just one of 3 under-the-radar stocks Wall Street's top analysts are quietly loading up on right now.
a month ago•Jessie Moore
ROKU
ABBV
VMI
Hot or Not, Stock Market Edition: 02/24/2026
Hot or Not, Stock Market Edition: 02/24/2026
Defense contractor V2X (VVX) just landed a seat on a $25 billion government contract and its stock is surging — plus another hot pick and 2 not-so-hot stocks to avoid.
a month ago•Jessie Moore
VVX
JBL
WHR
WFG
Nature’s Sunshine Products (NATR): The #1 Zen Rated Stock
Nature’s Sunshine Products (NATR): The #1 Zen Rated Stock
The Zen Ratings has an amazing track record in selecting winning stocks. Today after scanning 4,600+ potential stocks it has pinpointed Nature’s Sunshine Products (NATR) as the #1 pick. Read on for more…
a month ago•Steve Reitmeister
NATR
Hot or Not, Stock Market Edition: 02/20/2026
Hot or Not, Stock Market Edition: 02/20/2026
TechnipFMC (FTI) just flashed a major breakout signal — plus 3 more stocks making surprising moves (in both directions).
2 months ago•Jessie Moore
FTI
INTU
VRSN
SGRY
Amazon’s February Blues: Should Investors Pivot to These 2 Stocks?
Amazon’s February Blues: Should Investors Pivot to These 2 Stocks?
While Amazon (NASDAQ: AMZN) continues its February nosedive, savvy investors are quietly pivoting to this under-the-radar Chinese electronics reseller that's poised to thrive amid the AI chip shortage — and it's not who you'd expect.
2 months ago•Lyndon Seitz
AMZN
RERE
M
3 New Strong Buy Ratings from Top-Rated Analysts: 02/20/2026
3 New Strong Buy Ratings from Top-Rated Analysts: 02/20/2026
Flowserve Corp (FLS) is forecast to grow earnings 51% — plus 2 more under-the-radar stocks analysts are quietly loading up on right now.
2 months ago•Jessie Moore
FLS
HWM
NBIX
5 Stocks to Watch: Week of 2/23/2026
5 Stocks to Watch: Week of 2/23/2026
5 stocks to watch for the week of 2/23/2026 with potential for outperformance, including Hasbro (HAS) and more.
2 months ago•Jessie Moore
HAS
VRT
NBIX
FLS
VTRS
Hot or Not, Stock Market Edition: 02/19/2026
Hot or Not, Stock Market Edition: 02/19/2026
Amkor Technology (AMKR) just crushed Wall Street earnings expectations and is trading near its 52-week high — but that's not the only hot stock you need to know about right now.
2 months ago•Jessie Moore
AMKR
HCA
RCUS
CLSK
The Small Cap Insurer Transformation Everyone’s Missing
The Small Cap Insurer Transformation Everyone’s Missing
This "boring" Florida insurer has been quietly ripping higher — and the transformation driving its rise is something most investors are completely overlooking.
2 months ago•Corbin Buff
UVE
3 New Strong Buy Ratings from Top-Rated Analysts: 02/19/2026
3 New Strong Buy Ratings from Top-Rated Analysts: 02/19/2026
Tenet Healthcare (THC) is hitting multi-year highs on surging hospital demand — plus 2 more Strong Buy stocks analysts can't stop raving about.
2 months ago•Jessie Moore
VTRS
THC
HAS
2 Tickers To Buy the Dip On
2 Tickers To Buy the Dip On
These 2 stocks boast fresh discounts and near-immaculate fundamentals — including LiveRamp (RAMP) and more.
2 months ago•Mijuško Šibalić
RAMP
TASK
Hot or Not, Stock Market Edition: 02/17/2026
Hot or Not, Stock Market Edition: 02/17/2026
Medpace (MEDP) just crashed 23% — but analysts say this beaten-down clinical research stock is a screaming buy, plus 3 more stocks facing make-or-break moments right now.
2 months ago•Jessie Moore
MEDP
SMTC
COTY
BA
Why Now Is the Ideal Time to Buy AMD Shares
Why Now Is the Ideal Time to Buy AMD Shares
Advanced Micro Devices (AMD) isn’t just second fiddle to Nvidia. Here’s why it’s worth taking seriously in the near term (and why it could deliver potentially impressive gains).
2 months ago•Mijuško Šibalić
AMD
3 New Strong Buy Ratings from Top-Rated Analysts: 02/17/2026
3 New Strong Buy Ratings from Top-Rated Analysts: 02/17/2026
Vertiv Holdings Co (VRT) just exploded 20% in one week on a 252% order surge from the AI data center boom—plus 2 more stocks with Strong Buy ratings that analysts say could soar up to 30% in the next year.
2 months ago•Jessie Moore
BWA
ROST
VRT
Viatris (VTRS): 2 Catalysts Propelling THIS Stock of the Week
Viatris (VTRS): 2 Catalysts Propelling THIS Stock of the Week
Bloated large cap tech stocks are on the way out. Healthy growing pharmaceutical companies like Viatris (VTRS), trading under fair value, are back in fashion. Get the full story now…
2 months ago•Steve Reitmeister
VTRS
5 Stocks to Watch: Week of 2/16/2026
5 Stocks to Watch: Week of 2/16/2026
5 stocks to watch for the week of 2/16/2026, including Betterware de Mexico (BWMX), a company with 60% or more upside potential, according to experts — plus 4 more high-potential tickers.
2 months ago•Jessie Moore
BWMX
FDX
LTM
HLMN
VISN
1...456...50
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.